Taylor Whitman serves as a Partner at Epsilon Health Investors, where he is a member of the Firm's Investment Committee and focuses on origination, underwriting, and portfolio company management. He brings deep experience working with health systems, payors, and emerging healthcare companies, with a focus on digital health, tech-enabled services and innovative care delivery models.

Previously, Whitman was a Partner at Concord Health Partners, a healthcare-focused investment firm, from 2018 to 2024. During his tenure, he oversaw origination, underwriting, and portfolio investment monitoring and served on the Firm's Investment and Valuation Committees. He held board positions at multiple portfolio companies including Mivi Neurosciences, Inc., Post Acute Analytics, Medntion, Cylera, and Pieces and served as board observer to Smarter Technologies, Learn to Live and Neuroflow. Before Concord, Whitman was a Partner at Three Ocean Partners, a New York-based merchant bank, where he managed daily firm operations and led middle-market transactions across direct investment and M&A platforms.

Earlier in his career, he served as a senior banker at BDA Partners, a boutique M&A advisory firm specializing in cross-border transactions. There, he spearheaded healthcare sector advisory assignments for corporate and private equity clients while helping to manage the New York office operations.

Whitman began his career in finance at Citigroup Venture Capital Equity Partners (nka Court Square Capital Partners), a multi-sector private equity firm. He holds a Bachelor of Arts degree from the Carroll School of Management at Boston College.